(Q52866295)

English

Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.

scientific article published in December 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

ductal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Quinn CM

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

Ostrowski JL

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

Harkins L

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

Rice AJ

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

Loney DP

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

33

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

531-536

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Expression of BCL-2 in the developing human fetal and infant breast

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Bcl-2 and the regulation of programmed cell death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

What is the value of bcl-2 protein detection for histopathologists?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Prognostic value of bcl-2 expression in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1998.00505.X

21 January 2018

Identifiers

10.1046/J.1365-2559.1998.00505.X

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9870147

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52866295&oldid=1506523839"